Molecular basis of peripheral vs central benzodiazepine receptor selectivity in a new class of peripheral benzodiazepine receptor ligands related to alpidem

被引:99
作者
Anzini, M
Cappelli, A
Vomero, S
Giorgi, G
Langer, T
Bruni, G
Romeo, MR
Basile, AS
机构
[1] UNIV SIENA, DIPARTIMENTO FARMACOCHIM TECNOL, I-53100 SIENA, ITALY
[2] UNIV SIENA, CTR INTERDIPARTIMENTALE ANAL & DETERMINAZ STRUTTU, I-53100 SIENA, ITALY
[3] UNIV INNSBRUCK, INST PHARMACEUT CHEM, A-6020 INNSBRUCK, AUSTRIA
[4] UNIV SIENA, IST FARMACOL, I-53100 SIENA, ITALY
[5] NIDDKD, NEUROSCI LAB, NIH, BETHESDA, MD 20892 USA
关键词
D O I
10.1021/jm960325j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Alpidem (1), the anxiolytic imidazopyridine, has nanomolar binding affinity for both the central benzodiazepine receptor (CBR) and the peripheral benzodiazepine receptor (PER). A novel class of PER ligands related to alpidem has been designed by comparing the interaction models of alpidem with PER and CBR. Several compounds in this class have shown high selectivity for PER vs CBR, and the selectivity has been discussed in terms of interaction models. The binding behavior of the three selected compounds was extensively studied by competition and saturation assays, and the results suggest that they are capable of recognizing two sites labeled by [H-3]PK11195. The molecular structure of one of the most active compounds (4e) has been determined by X-ray diffraction and compared with that of alpidem. Molecular modeling studies suggest that the bioactive conformation of 4e is Likely to be very similar to the conformation found in the crystal.
引用
收藏
页码:4275 / 4284
页数:10
相关论文
共 27 条
[1]  
ADAMS DR, 1983, TETRAHEDRON LETT, V24, P517
[2]  
ANZINI M, 1994, HETEROCYCLES, V38, P103
[3]  
ANZINI M, 1992, FARMACO, V47, P191
[4]   NOVEL, POTENT, AND SELECTIVE 5-HT3 RECEPTOR ANTAGONISTS BASED ON THE ARYLPIPERAZINE SKELETON - SYNTHESIS, STRUCTURE, BIOLOGICAL-ACTIVITY, AND COMPARATIVE MOLECULAR-FIELD ANALYSIS STUDIES [J].
ANZINI, M ;
CAPPELLI, A ;
VOMERO, S ;
GIORGI, G ;
LANGER, T ;
HAMON, M ;
MERAHI, N ;
EMERIT, BM ;
CAGNOTTO, A ;
SKORUPSKA, M ;
MENNINI, T ;
PINTO, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) :2692-2704
[5]  
BASILE AS, 1987, J PHARMACOL EXP THER, V240, P1006
[6]   CHARACTERIZATION OF BENZODIAZEPINE RECEPTORS IN THE BOVINE PINEAL-GLAND - EVIDENCE FOR THE PRESENCE OF AN ATYPICAL BINDING-SITE [J].
BASILE, AS ;
KLEIN, DC ;
SKOLNICK, P .
MOLECULAR BRAIN RESEARCH, 1986, 1 (02) :127-135
[7]  
BOREA PA, 1987, MOL PHARMACOL, V31, P334
[8]  
Bourguignon J.J., 1993, PERIPHERAL BENZODIAZ, P59
[9]   SPECIFIC BENZODIAZEPINE RECEPTORS IN RAT-BRAIN CHARACTERIZED BY HIGH-AFFINITY [DIAZEPAM-H-3] BINDING - (AFFINITY BINDING DIAZEPAM ANXIOLYTIC ACTIVITY BRAIN MEMBRANES REGIONAL DISTRIBUTION) [J].
BRAESTRUP, C ;
SQUIRES, RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (09) :3805-3809
[10]   Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors [J].
Cappelli, A ;
Anzini, M ;
Vomero, S ;
Menziani, MC ;
DeBenedetti, PG ;
Sbacchi, M ;
Clarke, GD ;
Mennuni, L .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (04) :860-872